Top 7 China Healthcare System Companies 2025
China's healthcare system serves 1.4 billion people through a network of 1 million+ healthcare institutions, including 37,000+ hospitals and 1 million+ grassroots clinics. The total healthcare expenditure reached ¥9 trillion in 2024. Leading companies span hospital operation, health technology platforms, pharmaceutical distribution, medical equipment, and healthcare IT. The system is undergoing rapid digital transformation with telemedicine, AI diagnostics, and smart hospital initiatives driving efficiency improvements and expanding access to quality care across urban and rural areas.
United Family Healthcare (UFH)
Revenue: ¥5B+ (2024)
United Family Healthcare is China's largest premium private hospital operator, running a network of hospitals and clinics in Beijing, Shanghai, Guangzhou, Shenzhen, Tianjin, and other major cities. UFH provides international-standard healthcare services with JCI accreditation, serving expatriate communities and affluent Chinese patients. The company operates under the New Frontier Health umbrella and has been expanding its hospital network and ambulatory care centers across China's tier-1 and tier-2 cities.
Ping An Good Doctor
Registered users: 400M+
Ping An Good Doctor (平安好医生) operates China's largest internet hospital and online health consultation platform with over 400 million registered users and 100,000+ contracted doctors. The platform provides 24/7 online consultations, prescription services, hospital referrals, chronic disease management, and health management. Ping An Good Doctor has integrated with over 3,000 hospitals and 180,000 pharmacies nationwide. The company has shifted from advertising-driven to membership-driven revenue model.
Meinian Onehealth (美年健康)
Revenue: ¥10B+ (2024)
Meinian Onehealth is China's largest health checkup service provider, operating over 600 health examination centers across 300+ cities. The company provides standardized physical examinations, occupational health screening, and personalized health management services. Meinian serves over 30 million customers annually and has been investing in AI-powered screening technologies and precision health checkup packages targeting chronic disease early detection.
JD Health (京东健康)
Revenue: ¥50B+ (2024)
JD Health is China's largest online pharmaceutical retail platform, part of JD.com's health division. The platform operates JD Pharmacy (京东大药房), online doctor consultations, and healthcare supply chain services. JD Health served over 100 million active users in 2024, offering prescription drug delivery, OTC medicine, health supplements, and medical devices with same-day delivery in major cities. The company holds online pharmaceutical sales licenses and operates one of China's largest cold-chain drug delivery networks.
AliHealth (阿里健康)
Revenue: ¥30B+ (2024)
AliHealth, Alibaba's healthcare arm, operates a comprehensive digital health ecosystem including pharmaceutical e-commerce (Ali Pharmacy), medical services, tracing system for pharmaceuticals, and health insurance intermediation. The platform leverages Alibaba's e-commerce infrastructure and Cainiao logistics for pharmaceutical distribution. AliHealth serves over 300 million users through its various health platforms integrated into Alipay and Taobao.
Neusoft Medical Systems
Revenue: ¥8B+ (2024)
Neusoft Medical is China's leading healthcare IT and medical equipment company, providing hospital information systems (HIS), electronic medical records (EMR), picture archiving systems (PACS), and medical imaging equipment (CT, MRI). The company's healthcare IT solutions are deployed in over 5,000 Chinese hospitals. Neusoft Medical has been expanding its AI diagnostic capabilities for medical imaging and developing smart hospital solutions integrating IoT medical devices with hospital management systems.
Kingmed Diagnostics (金域检测)
Revenue: ¥12B+ (2024)
Kingmed Diagnostics is China's largest independent clinical laboratory testing company, operating over 700 laboratories across all Chinese provinces. The company provides over 3,000 test items including molecular diagnostics, pathology, clinical chemistry, and genetic testing. Kingmed serves 230,000+ medical institutions nationwide, enabling smaller hospitals and clinics to access advanced testing capabilities without in-house laboratory infrastructure.
Comparison Table
| Company | Segment | Scale | Users/Sites | Tech Focus | Growth | Revenue |
|---|---|---|---|---|---|---|
| United Family | Hospitals | Private premium | 30+ hospitals | JCI standard | 15%+ | ¥5B+ |
| Ping An Good Dr | Telemedicine | Largest online | 400M users | AI consultation | 20%+ | ¥7B+ |
| Meinian Onehealth | Health checkup | Largest chain | 600+ centers | AI screening | Moderate | ¥10B+ |
| JD Health | Pharma retail | Online leader | 100M+ users | Same-day delivery | 25%+ | ¥50B+ |
| AliHealth | Digital health | Ecosystem | 300M users | Alipay integration | 20%+ | ¥30B+ |
| Neusoft Medical | Healthcare IT | IT leader | 5,000+ hospitals | AI imaging | Moderate | ¥8B+ |
| Kingmed | Lab testing | Largest lab chain | 700+ labs | Molecular Dx | 15%+ | ¥12B+ |
Frequently Asked Questions
How large is China's healthcare system?
China's healthcare system encompasses 1 million+ healthcare institutions including 37,000+ hospitals (3,000+ tertiary hospitals, 11,000+ secondary, and 13,000+ primary), 980,000+ grassroots clinics, and 600,000+ village clinics. The system employs 12 million+ healthcare workers including 4.4 million doctors and 5.5 million nurses. Total healthcare expenditure reached approximately ¥9 trillion ($1.25 trillion) in 2024, representing about 7% of GDP, with continued annual growth of 8-10%.
How does China's hierarchical healthcare system work?
China's hierarchical healthcare system directs patients through three tiers: (1) Primary care — community health centers, township clinics, and village clinics handle common illnesses and preventive care; (2) Secondary care — county/district hospitals treat more complex conditions; (3) Tertiary care — provincial and national hospitals handle major diseases and specialized treatment. China is implementing a 'grading diagnosis and treatment' policy requiring patients to first visit primary care before being referred to higher-level hospitals, aiming to reduce overcrowding at major hospitals. Telemedicine platforms like Ping An Good Doctor facilitate this tiered referral system.
What is the role of telemedicine in China?
Telemedicine has expanded rapidly in China, accelerated by COVID-19 and supported by national internet hospital policies. China now has over 2,700 licensed internet hospitals. Major platforms include Ping An Good Doctor (400M+ users), JD Health, AliHealth, and WeDoctor. Services include online consultations, electronic prescriptions, drug delivery, remote monitoring, and chronic disease management. The National Health Commission has integrated telemedicine into the formal healthcare system, allowing internet hospital prescriptions and insurance reimbursement for online consultations in many provinces.
How does China's pharmaceutical distribution work?
China's pharmaceutical distribution system is undergoing reform with centralized procurement reducing drug prices by 50-80% for many medicines. Major distributors include Sinopharm (国药), Shanghai Pharma, and China Resources Pharmaceutical, operating national logistics networks covering hospitals and pharmacies. JD Health and AliHealth have become major online pharmaceutical channels. The Volume-Based Procurement (VBP) program now covers 400+ drug categories, and the system is shifting from hospital-centered to multi-channel distribution including retail pharmacies, online platforms, and direct-to-patient delivery.
What is China's hospital grading system?
China grades hospitals into three tiers with three levels each: Tertiary (三级, highest) — Tertiary Grade A (三甲) are top-level comprehensive hospitals with 500+ beds, handling major diseases and medical education; Secondary (二级) — county/district level with 100-500 beds; Primary (一级) — community health centers with basic services. China has approximately 3,000+ Tertiary Grade A (三甲) hospitals, concentrated in major cities and provincial capitals. Hospital grade affects treatment scope, insurance reimbursement rates, and patient willingness to travel for care.